Generates revenue from selling the HandX handheld modular robotic system for minimally invasive surgery and related single-use end-effector instruments, primarily through exclusive distributors.
Geographic Exposure
Europe94.59%
Israel0.6%
India0%
Revenue Drivers
HandX surgical system sales
Sales of handheld modular robotic surgical systems.
CORE61.05%
Disposable end-effector instrument sales
Sales of single-use sterile end-effectors for surgical procedures.
CORE38.95%
End Markets
Medical device distributors
Hospitals and medical centers (surgical departments)
Specializations
FDA clearanceCE Mark certificationIsrael AMAR medical device registrationExclusive distributor agreementsComputer vision and AI surgeon training simulatorClinical trials and marketing-driven clinical studies+1 more
Activities
Medical device R&D and product development
In-house manufacturing/assembly, quality control and packaging
